Charles Oh

Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ.

BreatheAmerica, Inc. provides services for health care management services. It offers its services in the areas of allergy tests, including skin tests, blood tests, and oral challenges; computerized tomography scans; endoscopy; immunotherapy; infusion therapy; and pulmonary functions. The company was founded by Ronald R. Charpentier, Joseph C. Hutts, Derril W. Reeves, Brook Bishop and David Hagaman in July 2007 and is headquartered in Franklin, TN.

Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA.

Roark Capital Group, Inc. (Roark Capital) is a private equity firm founded in 2001 by Neil K. Aronson. The firm is headquartered in Atlanta, Georgia.

Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999.

Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team.

FFL Partners LLC (FFL) is a private equity firm founded in 1997 by Tully Friedman, Spencer Fleischer, David Lowe, and Christopher Masto. The firm is headquartered in San Francisco, California.

Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas.

The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet.

Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.

The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus.

Ridoret Distribution SARL provides carpentry services. It specializes in doors and windows. The firm also provides client consulting. The company was founded on November 16, 1982 and is headquartered in La Rochelle, France.

Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA.

Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts.

Crossover Health, Inc. provides worksite health and wellness services. It offers primary, ancillary, and advanced services, includes urgent care, occupational health, preventive care, chronic disease management, health risk assessment, health education, health coaching, biometrics, physical therapy, chiropractic, acupuncture, specialist preferred network, care coordination, health analytics, and remote care. The company was founded by Scott Shreeve in 2010 and is headquartered in Aliso Viejo, CA.

Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.

Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA.

Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA.

Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023.

Syngenta Bangladesh Ltd. engages in agriculture services. The company is headquartered in Dhaka, Bangladesh.

Teal Bio, Inc. is a developer of innovative, reusable respiratory personal protective equipment. The company is based in Somerville, MA, and operates out of Greentown Labs, the largest climatetech incubator in the area. The company's patent-pending reusable mask and filter platform reduces waste, improves communication, and is more comfortable than existing N95 solutions. The company was founded by Carlo Giovanni Traverso, Jason Troutner, Robert S. Langer, James Byrne, Adam Wentworth.

Fairtility Ltd. is a company based in Tel Aviv, Israel that is advancing reproductive care through the power of transparent AI. Fairtility's flagship software, Chloe, is an AI-based decision support tool that provides clinicians complete visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation, and egg donation. The Israeli company aims to expand Chloe's application across the entire reproductive care journey, from assessing infertility causes to optimizing embryo transfer. Fairtility believes that transparency is critical when AI intersects with human life, and they are at the forefront of the new frontier of IVF data. The company was founded by Eran Eshed, Assaf Ben-Meir, and Itay Erlich, with Eran Eshed serving as the CEO since incorporation.

Mahana Therapeutics, Inc. manufactures and distributes digital therapeutics products. The company was founded by Simon Levy in 2018 and is headquartered in San Francisco, CA.

Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.

Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA.